James Gregory, MD
Sports Medicine · Houston, TXNPI 1639335359
Payments from drug & device makers
Across 789 payments — averaging $1074.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$715K
- Arthrex$127K
- Medinc Of Texas$4K
- Zimmer Biomet$1K
- Medtronic$215
- Exactech, Inc.$187
- plus $533 from 7 others
Across 4 payments — averaging $8377.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$23K
- Stryker$10K
What the payments were for
- Consulting fees$450,75180%
- Speaking & faculty fees$27,4705%
- Travel & lodging$67,79512%
- Food & beverage$16,4373%
- Education$2,6650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 691 | $715,087 |
| Arthrex | 64 | $127,069 |
| Medinc Of Texas | 14 | $3,799 |
| Zimmer Biomet | 9 | $1,016 |
| Medtronic | 3 | $215 |
| Exactech, Inc. | 1 | $187 |
| FX Shoulder Solutions, Inc | 1 | $162 |
| Arthrosurface Incorporated | 1 | $147 |
| Smith+Nephew | 1 | $140 |
| Catalyst Orthoscience | 1 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$311,680
- TORNIER PERFORM REVERSED GLENOID$175,971
- AEQUALIS PERFORM$133,093
- TORNIER PERFORM ANATOMIC AUGMENTED GLENOID$125,506
- TORNIER PERFORM REVERSED AUGMENTED GLENOID$100,421
- MAKO$48,516
- SIMPLICITI$42,147
- AEQUALIS PERFORM REVERSED$36,155
- AEQUALIS$20,700
- AEQUALIS REVERSED II$11,620
- ALPHAVENT$10,785
- R&D UPPER EXT$7,781
- AEQUALIS ASCEND FLEX$3,631
- SYSTEM 9 CD NXT$3,476
- BLUEPRINT PSI SYSTEM$3,259
- ADVANTIM$2,075
- SPY-PHI SYSTEM$2,025
- 1788$2,025
- REUNION$1,928
- NEW PRODUCT DEVELOPMENT$1,660
How this compares
$847,905 in reported general payments places this provider in the 95th percentile of 437 sports medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 132 | $3,191 |
| Oxycodone Hcl | 113 | $471 |
| Tramadol Hcl | 130 | $301 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $281 |
| Doxycycline Hyclate | 17 | $193 |
| Meloxicam | 78 | $177 |
| Ibuprofen | 23 | $175 |
| Cyclobenzaprine Hcl | 16 | $164 |
| Methylprednisolone | 13 | $85 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Houston
- Walter LoweHouston$1.4M
- David BrownHouston$920K
- Matthew HiggsHouston$634K
- Robert FullickHouston$141K
- Patrick McCullochHouston$136K
- Joshua HarrisHouston$109K
- David LintnerHouston$45K
- Mark AdickesHouston$35K
- Mufaddal GomberaHouston$33K
- Timothy VachrisAustin$5.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.